Accurately diagnosing and treating conditions among children can come with its challenges, and no parent wants to see their child suffer. Nearly everyone has experienced constipation at some point in…
It is not uncommon to experience symptoms of constipation, bloating, uncomfortable fullness, or abdominal pain after a large meal. However, when these symptoms persist or arise frequently enough to hinder…
Chronic constipation is a common health issue that has a variety of causes. It is estimated that up to 63 million people in North America live with chronic constipation.[i] Constipation…
Who qualifies for this research study?
Men ages 45-80 with Low Testosterone (hypogonadism) at an increased risk or history of
Cardiovascular Disease. The clinical site will be able to provide more information about additional
requirements for study participation.
Where are the research sites?
There are approximately 400 centers in the United States that are helping to conduct this study.
When will I know if I qualify for a study?
If you pass this initial screener, a member of a study doctor’s staff will contact you – they will ask
you more questions to further assess if you should participate in this study. If they believe that you
should be considered, you will be asked to schedule an appointment at the doctor’s office or clinic
for further evaluations. When you go to the doctor’s office, the study doctor and his/her team
conduct study related examinations and tests to see if you can be enrolled into this study.
How long will my participation in the study last, if I qualify?
Your participation may last for up to approximately 5 years. During this time, the study doctors will
monitor your health and progress.
What is the purpose of these research studies?
The purpose of this study is to evaluate the safety and effectiveness of an investigational
medication for Low Testosterone (hypogonadism) with an increased risk or history of
Cardiovascular Disease.
Low Testosterone or Hypergonadism
Who qualifies for this research study?
Men ages 45-80 with Low Testosterone (hypogonadism) at an increased risk or history of
Cardiovascular Disease. The clinical site will be able to provide more information about additional
requirements for study participation.
Where are the research sites?
There are approximately 400 centers in the United States that are helping to conduct this study.
When will I know if I qualify for a study?
If you pass this initial screener, a member of a study doctor’s staff will contact you – they will ask
you more questions to further assess if you should participate in this study. If they believe that you
should be considered, you will be asked to schedule an appointment at the doctor’s office or clinic
for further evaluations. When you go to the doctor’s office, the study doctor and his/her team
conduct study related examinations and tests to see if you can be enrolled into this study.
How long will my participation in the study last, if I qualify?
Your participation may last for up to approximately 5 years. During this time, the study doctors will
monitor your health and progress.
What is the purpose of these research studies?
The purpose of this study is to evaluate the safety and effectiveness of an investigational
medication for Low Testosterone (hypogonadism) with an increased risk or history of
Cardiovascular Disease.